The Rarest of the Rare: A Case of BAP1-Mutated Primary Peritoneal Mesothelioma

Aanchal Gupta1, Alisa Vasileva2, Sukesh Manthri3

  • 1Internal Medicine, St. Martinus University Faculty of Medicine, Willemstad, CUW.

Cureus
|November 2, 2021
PubMed

Insights

Rare malignant peritoneal mesothelioma (MPM) occurred in a young man without asbestos exposure. Genetic testing revealed a BAP1 gene mutation, highlighting its role in familial mesothelioma development.

Area of Science:

  • Oncology
  • Genetics

Background:

  • Malignant mesotheliomas (MM) are rare cancers, typically linked to asbestos exposure and most often affecting the pleura.
  • While asbestos is a primary risk factor, mutations in the BAP1 gene are increasingly recognized as a predisposing factor for MM and other cancers.

Observation:

  • A 43-year-old male presented with abdominal discomfort and was diagnosed with malignant peritoneal mesothelioma (MPM).
  • The patient had no significant occupational or environmental risk factors for mesothelioma but had a family history of mesothelioma and melanoma.

Findings:

  • Genetic testing revealed a BAP1 gene mutation in the patient, confirming a strong association with MPM development.
  • This case highlights a rare familial variant of mesothelioma, particularly in an unusual site like the peritoneum.

Implications:

  • Young patients diagnosed with MM, especially those without typical risk factors, should undergo germline testing for BAP1 mutations.
  • Identifying BAP1 mutations can aid in understanding familial cancer syndromes and inform genetic counseling and risk assessment.